TITLE

Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent

AUTHOR(S)
Park, Jun-Bean; Kang, Do-yoon; Yang, Han-Mo; Cho, Hyun-Jai; Park, Kyung Woo; Lee, Hae-Young; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Hyo-Soo
PUB. DATE
March 2013
SOURCE
European Heart Journal;Mar2013, Vol. 34 Issue 12, p920
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
86428953

 

Related Articles

  • Platelet reactivity after drug-eluting stent implantation predicted adverse outcomes.  // Hem/Onc Today;9/25/2013, Vol. 14 Issue 18, p8 

    The article highlights a study published in "The Lancet" by researcher Gregg W. Stone and colleagues which found that high platelet reactivity on clopidogrel after drug-eluting stent implantation was an independent predictor of stent thrombosis and myocardial infarction at one year.

  • Coronary-Artery Stents. Serruys, Patrick W.; Kutryk, Michael J.B.; Ong, Andrew T.L. // New England Journal of Medicine;2/2/2006, Vol. 354 Issue 5, p483 

    The article focuses on coronary-artery stents, interventional cardiology, drug-eluting stents, and "self-seeding" intravascular devices. Statistics are provided on risk reduction for adverse cardiac events and rates of angiographic restenosis in patients with drug-eluting stents. Studies on...

  • Acute ST-Elevation Myocardial Infarction after Coronary Stent Fracture. Rafighdust, Abbasali; Eshraghi, Ali // Journal of Tehran University Heart Center;2015, Vol. 10 Issue 4, p205 

    The invention of the drug-eluting stent (DES) has brought about revolutionary changes in the field of interventional cardiology. In the DES era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged. One of the emerging paradigms in the DES era is stent fracture....

  • Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature. Panduranga, Prashanth; Al-Mukhaini, Mohammed // Heart Views;Jan-Mar2011, Vol. 12 Issue 1, p22 

    Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation. Stent thrombosis commonly presents with myocardial infarction or death. We report a 41-year-old Arab male with...

  • Optimal Duration of Clopidogrel Use after Implantation of Drug-Eluting Stents � Still in Doubt. Berger, Peter B. // New England Journal of Medicine;4/15/2010, Vol. 362 Issue 15, p1441 

    The author reflects on whether stent thrombosis is a result of the use of drug-eluting stents and the required duration of dual antiplatelet therapy after implantation of drug-eluting stents. He explains the relationship between stent thrombosis and large myocardial infarction or death. The...

  • Hyporesponsiveness to Clopidogrel Does Not Predict 1-Year Mortality. Alexander, Lori // MD Conference Express;Dec2012, p22 

    The article discusses the findings of the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) trial. It shows that hyporesponsiveness to clopidogrel does not predict one-year mortality after percutaneous coronary intervention (PCI) with a drug-eluting stent (DES)....

  • Very Late Drug-Eluting Stent Thrombosis Post Exercise Stress Echocardiogram. Oqueli, Ernesto; Hiscock, Martin; Dick, Ronald // Heart, Lung & Circulation;Dec2008 Supplement 4, Vol. 17, pS21 

    Stent thrombosis, although a rare event, has been the object of considerable interest because of its attendant morbidity and mortality and has come into focus with the advent of drug-eluting stents. We report a case of very late drug-eluting stent thrombosis occurring immediately after an...

  • Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Grines, Cindy L.; Bonow, Robert O.; Casey Jr, Donald E.; Gardner, Timothy J.; Lockhart, Peter B.; Moliterno, David J.; O'Gara, Patrick; Whitlow, Patrick // Journal of the American Dental Association (JADA);May2007, Vol. 138 Issue 5, p652 

    The article warns against premature discontinuation of dual antiplatelet therapy after coronary stenting. According to the authors, discontinuation of antiplatelet therapy greatly increases the risk of stent thrombosis, myocardial infarction and death. The authors stress the importance of 12...

  • A Practical Guide to the Management of Subacute Stent Thrombosis. Vinall, Maria // MD Conference Express;Oct2011, p31 

    The article focuses on the strategies in managing subacute stent thrombosis. It notes that stent thrombosis can happen after stent implantation which arise with bare mental stents (BMS) and drug-eluting stents (DES). It mentions the significance of a correct diagnosis to achieve the proper...

  • Antiplatelets/heparin/sirolimus.  // Reactions Weekly;4/28/2012, Issue 1399, p7 

    The article describes the cases of two men who developed coronary stent thrombosis and myocardial infarction following implantation of sirolimus-eluting stents, despite being administered with antiplatelets and heparin, after undergoing multidigit replantation.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics